Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated:  12/31/1969
Boston University Medical Center
mi
from
Boston, MA
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated: 12/31/1969
Boston University Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated:  12/31/1969
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated: 12/31/1969
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated:  12/31/1969
University of Mississippi Medical Center
mi
from
Jackson, MS
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated: 12/31/1969
University of Mississippi Medical Center
mi
from
Jackson, MS
Click here to add this to my saved trials
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated:  12/31/1969
Saint Louis University
mi
from
Saint Louis, MO
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated: 12/31/1969
Saint Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated:  12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated: 12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated:  12/31/1969
Temple University Hospital
mi
from
Middletown, NY
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated: 12/31/1969
Temple University Hospital
mi
from
Middletown, NY
Click here to add this to my saved trials
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated:  12/31/1969
Winthrop University Hospital Clinical Trials Center
mi
from
Mineola, NY
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated: 12/31/1969
Winthrop University Hospital Clinical Trials Center
mi
from
Mineola, NY
Click here to add this to my saved trials
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated:  12/31/1969
Mount Carmel Medical Group
mi
from
Columbus, OH
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated: 12/31/1969
Mount Carmel Medical Group
mi
from
Columbus, OH
Click here to add this to my saved trials
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated:  12/31/1969
Oklahoma Heart Hospital
mi
from
Oklahoma City, OK
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated: 12/31/1969
Oklahoma Heart Hospital
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated:  12/31/1969
Allegheny General Hospital
mi
from
Pittsburgh, PA
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated: 12/31/1969
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated:  12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated: 12/31/1969
Houston Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated:  12/31/1969
CardioPulmonary Research Center
mi
from
Guaynabo,
Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Multicenter, Retrospective Chart Review of First-time Opsumit® (Macitentan) Users in the United States
Status: Enrolling
Updated: 12/31/1969
CardioPulmonary Research Center
mi
from
Guaynabo,
Click here to add this to my saved trials
The Feasibility of a Web-based Application to Monitor Home Blood Pressure
The Feasibility of a Web-based Application to Monitor Home Blood Pressure
Status: Enrolling
Updated:  12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
The Feasibility of a Web-based Application to Monitor Home Blood Pressure
The Feasibility of a Web-based Application to Monitor Home Blood Pressure
Status: Enrolling
Updated: 12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Association Between Genetic Algorithm to Predict Hypertension Therapy and Response to Treatment
Association Between a Pharmacogenetic Algorithm to Predict Blood Pressure Therapy With Blood Pressure Response to Anti-Hypertensive Therapy
Status: Enrolling
Updated:  12/31/1969
Fairview Clinic - New Brighton
mi
from
New Brighton, MN
Association Between Genetic Algorithm to Predict Hypertension Therapy and Response to Treatment
Association Between a Pharmacogenetic Algorithm to Predict Blood Pressure Therapy With Blood Pressure Response to Anti-Hypertensive Therapy
Status: Enrolling
Updated: 12/31/1969
Fairview Clinic - New Brighton
mi
from
New Brighton, MN
Click here to add this to my saved trials
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Arizona Eye Center
mi
from
Chandler, AZ
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Arizona Eye Center
mi
from
Chandler, AZ
Click here to add this to my saved trials
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Sall Research Medical Center, Inc.
mi
from
Artesia, CA
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Sall Research Medical Center, Inc.
mi
from
Artesia, CA
Click here to add this to my saved trials
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
United Med Res Inst
mi
from
Inglewood, CA
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
United Med Res Inst
mi
from
Inglewood, CA
Click here to add this to my saved trials
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Eye Research Foundation
mi
from
Newport Beach, CA
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Eye Research Foundation
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Rocky Mountain Lions Eye Inst
mi
from
Aurora, CO
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Rocky Mountain Lions Eye Inst
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Eye Care Centers Management/Clayton Eye Center
mi
from
Morrow, GA
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Eye Care Centers Management/Clayton Eye Center
mi
from
Morrow, GA
Click here to add this to my saved trials
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Coastal Research Associates, LLC
mi
from
Roswell, GA
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Coastal Research Associates, LLC
mi
from
Roswell, GA
Click here to add this to my saved trials
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/31/1969
Texan Eye/Keystone Research
mi
from
Austin, TX
A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
A Phase I, Multi-Center, Randomized, Adaptive, Investigator/Patient Masked, Multiple-Ascending Dose, Placebo and Active Comparator-Controlled Parallel Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Topical Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Texan Eye/Keystone Research
mi
from
Austin, TX
Click here to add this to my saved trials
The Smart Hypertension Control Study
Improving Hypertension Using a Smartphone-Enabled Personal Control Program: The Smart Hypertension Control Study
Status: Enrolling
Updated:  12/31/1969
Northwestern Medical Group
mi
from
Chicago, IL
The Smart Hypertension Control Study
Improving Hypertension Using a Smartphone-Enabled Personal Control Program: The Smart Hypertension Control Study
Status: Enrolling
Updated: 12/31/1969
Northwestern Medical Group
mi
from
Chicago, IL
Click here to add this to my saved trials
Minding GOALS: An Internet-Assisted Mind-Body-Behavior Program for Blood Pressure Control
An Internet-Assisted Mind-Body-Behavior Program for Blood Pressure Control
Status: Enrolling
Updated:  12/31/1969
Center for Research on Health Care, University of Pittsburgh
mi
from
Pittsburgh, PA
Minding GOALS: An Internet-Assisted Mind-Body-Behavior Program for Blood Pressure Control
An Internet-Assisted Mind-Body-Behavior Program for Blood Pressure Control
Status: Enrolling
Updated: 12/31/1969
Center for Research on Health Care, University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Dimas, CA
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Dimas, CA
Click here to add this to my saved trials
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Hollywood, FL
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Port Charlotte, FL
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Dunwoody, GA
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dunwoody, GA
Click here to add this to my saved trials
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bethlehem, PA
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
El Paso, TX
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Miami Lakes, FL
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
mi
from
Sofia,
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
mi
from
Sofia,
Click here to add this to my saved trials
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Ann Arbor, MI
Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
A Randomized, Double-Blind, Placebo Controlled, Parallel Group Study of Patiromer for the Enablement of Spironolactone Use for Blood Pressure Control in Patients With Resistant Hypertension and Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Urban Zen Integrative Therapy for Persons With Pulmonary Hypertension
Feasibility and Acceptability of an Integrative Therapy for Symptom Management in Persons With Pulmonary Hypertension
Status: Enrolling
Updated:  12/31/1969
The Ohio State University Ross Heart Hospital
mi
from
Columbus, OH
Urban Zen Integrative Therapy for Persons With Pulmonary Hypertension
Feasibility and Acceptability of an Integrative Therapy for Symptom Management in Persons With Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
The Ohio State University Ross Heart Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Pharmacogenomic Evaluation of Antihypertensive Responses
Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR)
Status: Enrolling
Updated:  12/31/1969
University of Florida Department of Community Health and Family Medicine
mi
from
Gainesville, FL
Pharmacogenomic Evaluation of Antihypertensive Responses
Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR)
Status: Enrolling
Updated: 12/31/1969
University of Florida Department of Community Health and Family Medicine
mi
from
Gainesville, FL
Click here to add this to my saved trials
Pharmacogenomic Evaluation of Antihypertensive Responses
Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR)
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Atlanta, GA
Pharmacogenomic Evaluation of Antihypertensive Responses
Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR)
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Pharmacogenomic Evaluation of Antihypertensive Responses
Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR)
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Pharmacogenomic Evaluation of Antihypertensive Responses
Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR)
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
24-hour Blood Pressure Measurements and Ischemic Conditioning
24-hour Blood Pressure Measurements and Ischemic Conditioning
Status: Enrolling
Updated:  12/31/1969
Dr. Hirofumi Tanaka
mi
from
Austin, TX
24-hour Blood Pressure Measurements and Ischemic Conditioning
24-hour Blood Pressure Measurements and Ischemic Conditioning
Status: Enrolling
Updated: 12/31/1969
Dr. Hirofumi Tanaka
mi
from
Austin, TX
Click here to add this to my saved trials
Study of Macronutrients and Heart Disease Risk
Macronutrient Composition of Diet and Risk Factors for Cardiovascular Disease
Status: Enrolling
Updated:  12/31/1969
Tulane University Office of Health Research
mi
from
New Orleans, LA
Study of Macronutrients and Heart Disease Risk
Macronutrient Composition of Diet and Risk Factors for Cardiovascular Disease
Status: Enrolling
Updated: 12/31/1969
Tulane University Office of Health Research
mi
from
New Orleans, LA
Click here to add this to my saved trials
The Role of Endothelin in Pulmonary Hypertension
The Role of Endothelin in Pulmonary Hypertension
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
The Role of Endothelin in Pulmonary Hypertension
The Role of Endothelin in Pulmonary Hypertension
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Nebivolol Versus Metoprolol: Comparative Effects on Fatigue and Quality of Life
Nebivolol Vs. Metoprolol: Comparative Effects on Fatigue and Quality of Life
Status: Enrolling
Updated:  12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Nebivolol Versus Metoprolol: Comparative Effects on Fatigue and Quality of Life
Nebivolol Vs. Metoprolol: Comparative Effects on Fatigue and Quality of Life
Status: Enrolling
Updated: 12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH
An Open-Label, Dose Titration Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046, A Sustained-Release Analogue of Vasoactive Intestinal Peptide, In Adult Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
Allegheny General Hospital
mi
from
Pittsburgh, PA
A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH
An Open-Label, Dose Titration Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046, A Sustained-Release Analogue of Vasoactive Intestinal Peptide, In Adult Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH
An Open-Label, Dose Titration Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046, A Sustained-Release Analogue of Vasoactive Intestinal Peptide, In Adult Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  12/31/1969
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
A Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046 in Subjects With PAH
An Open-Label, Dose Titration Study to Assess the Safety, Tolerability, and Hemodynamic Response of PB1046, A Sustained-Release Analogue of Vasoactive Intestinal Peptide, In Adult Subjects With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Treating Nocturnal Hypertension and Nocturia in African American Men
A Pilot Study: Treating Nocturnal Hypertension and Nocturia in African American Men
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Treating Nocturnal Hypertension and Nocturia in African American Men
A Pilot Study: Treating Nocturnal Hypertension and Nocturia in African American Men
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials